About
HEPTA Medical is a private medical device company founded in 2019 and based in Suresnes, France. The company specializes in developing innovative, minimally invasive treatments for early-stage lung cancer. Originating from the MD Start incubator and supported by Sofinnova Partners, HEPTA Medical focuses on addressing significant challenges in lung cancer treatment. The company's core innovation is a microwave ablation platform designed to treat pulmonary nodules without surgery or radiation. This platform features a flexible microwave ablation probe compatible with any lung navigation system and includes a proprietary tissue temperature sensor for real-time monitoring during procedures. Additionally, HEPTA Medical integrates predictive software powered by artificial intelligence to enhance procedural accuracy and safety by visualizing the ablation zone in real-time. HEPTA Medical aims to advance minimally invasive thermal ablation therapy for early lung cancer, with ongoing preclinical validations and plans for clinical trials. The company is actively seeking strategic partnerships to support its clinical entry and development. Its primary customers include pulmonologists, thoracic surgeons, and medical centers specializing in lung cancer diagnosis and treatment.
Technologies
Keywords
Company Information
-
Employees 10
-
Founded 2018
Location
11 Rue Gardenat-Lapostol, Suresnes, Ile-de-France, France, 92150
